| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000034451 |
| Receipt No. | R000039286 |
| Official scientific title of the study | A study for an effect of the food containing plant-derived ingredient on serum fat. |
| Date of disclosure of the study information | 2018/10/22 |
| Last modified on | 2019/01/07 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | A study for an effect of the food containing plant-derived ingredient on serum fat. | |
| Title of the study (Brief title) | Effect of plant-derived ingredient on serum fat. | |
| Region |
|
|
| Condition | |||
| Condition | Nothing (Healthy adults) | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate the efficacy of the plant-derived ingredient on post prandial serum fat. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Post prandial serum fat |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Single intake of active food (product code: Q-001) > wash out more than 5 days > Single intake of placebo food (product code: P-001) | |
| Interventions/Control_2 | Single intake of placebo food (product code: P-001) > wash out more than 5 days > Single intake of active food (product code: Q-001) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Age>=30 and <60 years
2.BMI>=18.5 and < 30 kg/m2 |
|||
| Key exclusion criteria | 1.Person who is presence of liver, kidney, and heart disease; respiratory, endocrine, metabolic, nervous system, or cognitive disorders; or diabetes or other diseases.
2.Person who has surgery within 2 months before the trial. 3.Person who taking medications for hyperglycaemia, lipid metabolism, or hypertension. 4.Person who taking supplements or foods that affect this trial. 5.Person who experienced unpleasant feeling during drawing blood. 6.Person who has donated over 200 mL blood within one month. 7.Person whose serum TG is over 200 mg/dL. 8.Person who is heavy smoker 9.Person who has food allergies. 10.Person who is shift worker. 11.Person who plans business trip lasting 5 consecutive days or more. 12.Person who participating or planning to participating in other clinical trial. 13.Person who can't agree informed consent. 14.Person who is pregnant or lactating 15.Person who is judged to be inappropriate for this study by the supervising physician or principal investigator for other reasons. |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Takahiro Ono |
| Organization | Ueno-Asagao Clinic |
| Division name | Head |
| Address | Kairaku Building 6F, 2-7-5, Higashiueno, Taito-ku, Tokyo, 110-0015, JAPAN |
| TEL | +81-3-6240-1162 |
| t.ono@ueno-asagao.clinic | |
| Public contact | |
| Name of contact person | Ryoma Shimizu |
| Organization | TES Holdings Co., Ltd. |
| Division name | Administrative Department of Clinical Trials |
| Address | Kairaku Building 6F, 2-7-5, Higashiueno, Taito-ku, Tokyo, 110-0015, JAPAN |
| TEL | +81-3-6801-8480 |
| Homepage URL | |
| r.shimizu@tes-h.co.jp | |
| Sponsor | |
| Institute | TES Holdings Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | うえのあさがおクリニック(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039286 |